Understanding the Role of Patient Feasibility in the Planning of Decentralized Trials

Since the onset of Covid, have Decentralized Clinical Trials lived up to their potential, and where do the principal challenges for DCT lie today? Join us for an intriguing exploration with one of the leading figures in Decentralized Trials, Craig Lipset, alongside Maya Zlatanova, a pioneer in integrating innovative technologies for predicting and solving patient recruitment challenges.

In this session, we will delve into the critical gaps of traditional country and site selection, unveiling the vital information that is often overlooked but crucial for the successful execution of decentralized trials. Discover how leveraging technology such as advanced insight extraction algorithms can provide a deeper understanding of the cultural, demographic, and disease-related specifics and inform where DCT could be the winning strategy.

Emphasizing the imperative need for improved feasibility assessments, we will introduce and underscore the value of Patient Feasibility as an innovative process that ensures a holistic and informed approach to trial planning.